From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer

Esophageal and gastric cancers represent tumors with poor prognosis. Unfortunately, radiotherapy, chemotherapy, and targeted therapy have made only limited progress in recent years in improving the generally disappointing outcome. Immunotherapy with checkpoint inhibitors is a novel treatment approac...

Descripción completa

Detalles Bibliográficos
Autores principales: Vrána, David, Matzenauer, Marcel, Neoral, Čestmír, Aujeský, René, Vrba, Radek, Melichar, Bohuslav, Rušarová, Nikol, Bartoušková, Marie, Jankowski, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337592/
https://www.ncbi.nlm.nih.gov/pubmed/30577521
http://dx.doi.org/10.3390/ijms20010013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337592/
https://www.ncbi.nlm.nih.gov/pubmed/30577521
http://dx.doi.org/10.3390/ijms20010013

Ejemplares similares